- Home
- HTOO vs APM Comparison
HTOO vs APM Comparison
Compare HTOO & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTOO
- APM
- Stock Information
- Founded
- HTOO 2020
- APM 2010
- Country
- HTOO Ireland
- APM United Kingdom
- Employees
- HTOO N/A
- APM N/A
- Industry
- HTOO Natural Gas Distribution
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- HTOO Utilities
- APM Health Care
- Exchange
- HTOO Nasdaq
- APM Nasdaq
- Market Cap
- HTOO 6.1M
- APM 6.1M
- IPO Year
- HTOO N/A
- APM 2018
- Fundamental
- Price
- HTOO $0.20
- APM $0.99
- Analyst Decision
- HTOO
- APM
- Analyst Count
- HTOO 0
- APM 0
- Target Price
- HTOO N/A
- APM N/A
- AVG Volume (30 Days)
- HTOO 589.6K
- APM 92.1K
- Earning Date
- HTOO 01-01-0001
- APM 07-07-2025
- Dividend Yield
- HTOO N/A
- APM N/A
- EPS Growth
- HTOO N/A
- APM N/A
- EPS
- HTOO N/A
- APM N/A
- Revenue
- HTOO $1,661,663.00
- APM N/A
- Revenue This Year
- HTOO $4,832.46
- APM N/A
- Revenue Next Year
- HTOO $81.82
- APM N/A
- P/E Ratio
- HTOO N/A
- APM N/A
- Revenue Growth
- HTOO N/A
- APM N/A
- 52 Week Low
- HTOO $0.19
- APM $0.46
- 52 Week High
- HTOO $1.02
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- HTOO 21.53
- APM 47.58
- Support Level
- HTOO $0.19
- APM $1.01
- Resistance Level
- HTOO $0.32
- APM $1.06
- Average True Range (ATR)
- HTOO 0.03
- APM 0.10
- MACD
- HTOO -0.01
- APM -0.02
- Stochastic Oscillator
- HTOO 3.41
- APM 15.68
About HTOO Fusion Fuel Green PLC
Fusion Fuel Green PLC is a company that has developed a Green Hydrogen production technology. It is focused on generating cost-effective and competitively priced Green Hydrogen.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.